Updates are available Correction dated 2022-09-06
Click to view Correction: https://doi.org/10.1007/s00592-022-01962-4
-
Authors
Rathmann, Wolfgang https://orcid.org/0000-0001-7804-1740
Kostev, Karel https://orcid.org/0000-0002-2124-7227
-
Funding
Funding for this research was provided by:
Deutsches Diabetes-Zentrum (DDZ)
- License Information
-
More Information
Article History
Received: 17 May 2022
Accepted: 10 July 2022
First Online: 6 August 2022
Change Date: 6 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00592-022-01962-4
Declarations
:
: WR reports the receipt of consulting fees for attending educational sessions or advisory boards run by AstraZeneca, Boehringer Ingelheim, NovoNordisk and IQVIA and institutional research grants from NovoNordisk outside of the topic of the current study. KK is an employee of IQVIA, a healthcare data science company in Germany.
: Ethical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
: This manuscript has not been published or presented elsewhere in part or in entirety, and is not under consideration by another journal.
